1. Efficacy of crizotinib and pemetrexed-based chemotherapy in Chinese NSCLC patients with ROS1 rearrangement
   Limin Zhang et al, 2016, Oncotarget CrossRef
2. Testing for ROS1 in non-small cell lung cancer: a review with recommendations
   Lukas Bubendorf et al, 2016, Virchows Archiv CrossRef